What Dosage of Testosterone Do Women Actually Need?

Women need testosterone. That sentence surprises a lot of people. Most of us grow up thinking testosterone is a male hormone, but the truth is that women produce it too, and when levels drop, the effects on energy, libido, mood, cognition, and body composition can be significant.

Yet the conversation around testosterone dosage for women is rarely straightforward. There is no FDA-approved testosterone product specifically designed for women in the United States. Dosing is done off-label, guided by clinical judgment and lab work. That means the quality of your care depends almost entirely on how experienced your provider is.

At 1st Optimal, we work with women navigating this territory every day. This guide is designed to give you an honest, evidence-based picture of what appropriate testosterone support for women looks like, including what levels matter, how therapy is administered, and how individualized dosing is determined. If you have ever felt dismissed when raising this topic with a conventional doctor, you are not alone. And this post is for you.

Why Women Need Testosterone

The idea that testosterone is a “male hormone” is one of the most persistent misconceptions in reproductive medicine. The reality is more nuanced. In women, testosterone is produced by the ovaries and adrenal glands and plays a central role in a wide range of physiological functions.

Research published in the Journal of Clinical Endocrinology and Metabolism has documented testosterone’s role in supporting libido, bone density, muscle mass, cognitive function, mood regulation, and energy metabolism in women. The hormone does not operate in isolation, it interacts with estrogen, progesterone, cortisol, and thyroid hormone in a complex hormonal ecosystem.

Women’s testosterone levels peak in their twenties and decline steadily with age. By the time a woman reaches menopause, her testosterone levels may be at 25 to 50 percent of what they were in her youth. This decline is not always dramatic, and many women are never informed that it is happening.

When levels fall below the range needed for optimal function, even if they are technically within the lower end of “normal” on standard lab panels, the impact on quality of life can be meaningful. This is why the question of appropriate dosage matters so much. Too little provides no benefit. Too much can cause unwanted side effects. The goal is precision.

Normal Testosterone Levels in Women: What the Labs Actually Mean

Understanding lab values is the first step in any meaningful conversation about testosterone therapy for women. Testosterone is typically measured in nanograms per deciliter (ng/dL), and reference ranges can vary by laboratory and assay method.

General reference ranges for total testosterone in women are often cited as 15 to 70 ng/dL, though some labs use a broader range of 8 to 60 ng/dL. Free testosterone, the biologically active form not bound to proteins, is typically measured in picograms per milliliter (pg/mL) and is often considered a more functionally relevant marker.

But here is the thing: standard reference ranges are built around statistical averages, not optimal health. A woman whose total testosterone sits at 18 ng/dL is technically “within range,” but she may be experiencing significant symptoms because her personal optimal was previously 55 ng/dL. Population-level normals do not capture individual variation.

This is why at 1st Optimal, we use comprehensive lab panels that include:

  • Total testosterone
  • Free testosterone
  • Sex hormone-binding globulin (SHBG), which affects how much testosterone is available for use
  • Estradiol and progesterone
  • DHEA-S, a precursor hormone produced by the adrenal glands
  • Complete metabolic panel and thyroid markers for context

Without this full picture, prescribing testosterone is guesswork. With it, dosing can be genuinely individualized.

Recognizing Low Testosterone in Women: Symptoms and Signs

Low testosterone in women is underdiagnosed. Many women report symptoms for years before anyone checks their testosterone levels, and even then, they are often told their values are “normal” without any nuanced discussion of what normal means for them specifically.

Symptoms that may indicate suboptimal testosterone in women include:

Energy and Vitality

  • Persistent fatigue that is not explained by poor sleep or other conditions
  • Reduced stamina and physical endurance
  • Difficulty recovering from exercise

Sexual Health

  • Decreased libido or loss of interest in sex
  • Reduced genital sensitivity or difficulty reaching orgasm
  • Vaginal dryness (though this is often more tied to estrogen)

Cognitive and Emotional Function

  • Brain fog and difficulty with word retrieval or focus
  • Low mood, increased anxiety, or emotional flatness
  • Reduced motivation and drive

Body Composition

  • Difficulty maintaining muscle mass despite consistent exercise
  • Increased fat accumulation, particularly around the abdomen
  • Reduced physical strength

Bone and Joint Health

  • Bone density loss beyond what is expected for age
  • Joint achiness or reduced connective tissue resilience

Research published in Menopause: The Journal of the Menopause Society found that testosterone therapy in postmenopausal women was associated with improvements in sexual function, mood, and bone health outcomes. The Global Consensus Position Statement on the Use of Testosterone Therapy for Women, published in 2019 across multiple journals simultaneously, confirmed that testosterone therapy can effectively address hypoactive sexual desire disorder and has a favorable safety profile when dosed appropriately.

If you are experiencing several of these symptoms and have not had your testosterone checked as part of a comprehensive panel, that is a meaningful gap in your care.

How Testosterone Therapy for Women Is Administered

Because no FDA-approved testosterone product exists specifically for women in the US, clinicians use compounded or off-label preparations. Several delivery methods are used, each with distinct absorption profiles and clinical considerations.

Topical Creams and Gels Compounded testosterone creams or gels are among the most commonly used forms for women. They are typically applied to the inner wrist, inner thigh, or labia minora, areas with good absorption. Dosing is highly adjustable, which makes these preparations particularly useful for fine-tuning.

One advantage of topical application is the ability to make incremental dose changes. One consideration is that application must be consistent, and the cream can inadvertently transfer to partners or children through skin contact if precautions are not taken.

Subcutaneous Pellets Pellets are small, rice-sized implants inserted under the skin, typically in the hip area, by a trained provider. They release testosterone steadily over three to six months, which eliminates the need for daily application.

Testosterone pellets for women have gained popularity because they deliver consistent levels without peaks and troughs. However, dosing adjustments cannot be made mid-cycle, you commit to a dose until the pellet is absorbed. This makes the initial dosing decision particularly important.

Injections Subcutaneous testosterone injections are used in some clinical settings for women, often at much lower concentrations than those used for men. They allow more flexible dosing and can be self-administered at home once trained.

Sublingual and Troches Some compounding pharmacies produce sublingual tablets or troches (lozenges) that dissolve under the tongue or in the cheek. Absorption can be variable with this method, and a portion of the dose may be swallowed rather than absorbed through the mucosa.

What Dosage Ranges Are Used in Clinical Practice

This is the question at the heart of this post, and I want to be direct with you: dosage varies considerably depending on the delivery method, the individual’s starting point, and the clinical goals. There is no universal right answer, which is precisely why working with a knowledgeable provider matters.

That said, I can share what the evidence and clinical guidelines suggest for women.

The Global Consensus Position Statement recommends that when testosterone is used in women, target levels should remain within the physiological range for premenopausal women, roughly 15 to 70 ng/dL for total testosterone. The statement explicitly cautions against supraphysiological dosing, meaning levels that exceed what a healthy premenopausal woman would naturally produce.

Typical dosing considerations by delivery method:

For topical preparations, women are often started at the low end of the therapeutic range and titrated upward based on symptom response and repeat lab values. Small adjustments, as modest as a fraction of a milligram, can make a meaningful difference in a woman’s experience.

For pellet therapy, doses are calculated based on body weight, symptom severity, activity level, and lab baseline. Women typically receive substantially lower doses than men, and providers experienced in pellet therapy for women often have proprietary dosing algorithms developed through clinical experience.

For injections, dosing frequency and concentration are adjusted to maintain steady physiological levels without sharp spikes.

What I always tell our patients at 1st Optimal: the goal is not to have a specific number on paper. The goal is to feel like yourself again, energetic, sharp, physically capable, interested in life and intimacy, while keeping your labs in a range that is safe and sustainable for the long term.

How Dosing Is Individualized: The Lab-Driven Approach

Starting testosterone therapy for women is not a set-it-and-forget-it protocol. It requires follow-up, monitoring, and a willingness to adjust based on how a patient responds. This is where experience separates exceptional care from average care.

At 1st Optimal, our general process looks like this:

Baseline Assessment Before any therapy begins, we obtain comprehensive labs, take a detailed symptom history, review current medications and supplements, and discuss the patient’s goals and lifestyle. This baseline is the map we navigate from.

Initial Dosing We start conservatively. It is much easier to increase a dose than to manage unwanted side effects from starting too high. This philosophy applies especially to women, where the therapeutic window is narrower than in men.

Four-to-Six Week Follow-Up After a short trial period, we recheck labs and review symptoms. Are energy levels improving? Has libido shifted? Is mood more stable? These subjective reports matter as much as the lab values. We also check for any early signs of excess, which I will address in the next section.

Ongoing Monitoring Once a stable dose is established, we typically monitor every three to six months. Hormonal needs are not static, they can shift with stress, changes in body composition, other medications, or life circumstances.

SHBG: The Variable That Changes Everything One commonly overlooked factor in testosterone dosing for women is sex hormone-binding globulin (SHBG). SHBG binds to testosterone in the bloodstream, rendering it unavailable for use. A woman with high SHBG may have a “normal” total testosterone but very little free testosterone available for her tissues.

Factors that raise SHBG include oral estrogen (including oral contraceptives), thyroid disorders, and certain medications. When SHBG is high, the effective testosterone dose may need to be adjusted to compensate. Conversely, certain conditions lower SHBG, which affects how much total testosterone is needed to achieve adequate free testosterone levels.

Testosterone and Other Hormones: How They Interact

No hormone operates in a vacuum. Testosterone’s effects in women are shaped by the broader hormonal environment, and any discussion of dosing should include at least a brief look at how testosterone interacts with other key hormones.

Testosterone and Estrogen Testosterone can convert to estradiol through a process called aromatization. In women already on estrogen therapy, this interaction requires careful monitoring to prevent estrogen levels from rising above the therapeutic target. In women not on estrogen, some conversion is normal and may even be beneficial for bone and cardiovascular health.

Testosterone and Progesterone Progesterone plays an important counterbalancing role in women’s hormonal health. Many functional medicine clinicians view the ratio of progesterone to estrogen as clinically significant. Progesterone also has its own effects on mood, sleep, and anxiety. When testosterone therapy is introduced, the entire hormonal picture is considered, not just one number.

Testosterone and DHEA DHEA (dehydroepiandrosterone) is a precursor hormone produced by the adrenal glands that converts into both testosterone and estrogen. Some clinicians prefer to support DHEA levels first, particularly in perimenopausal women, before moving to direct testosterone therapy. This approach is gentler and may be appropriate for mild deficiency.

Testosterone and Thyroid Hypothyroidism affects SHBG levels and can mimic or exacerbate symptoms of low testosterone. For this reason, a thorough thyroid panel is always part of our baseline workup. Treating thyroid dysfunction first sometimes resolves testosterone-related symptoms without requiring testosterone therapy at all.

Risks, Considerations, and What to Watch For

Testosterone therapy for women, when appropriately dosed, has a favorable safety profile. However, there are important considerations that every woman should understand before starting.

Signs of Supraphysiological Dosing The most common side effects of excess testosterone in women are:

  • Acne, particularly along the jawline and back
  • Increased facial or body hair (hirsutism)
  • Oily skin
  • Scalp hair thinning
  • Clitoral enlargement (at very high doses)
  • Deepening of the voice (at very high doses, and often not reversible)

These effects are generally dose-dependent and can be minimized by careful titration and monitoring. They are much more likely with supraphysiological dosing than with therapy that keeps levels within the premenopausal female range.

Cardiovascular Considerations The evidence on testosterone and cardiovascular risk in women is more nuanced than in men. The Global Consensus Statement concluded that short-term testosterone use in women does not appear to increase cardiovascular risk, but long-term data are still limited [5]. Women with existing cardiovascular conditions should discuss the risk-benefit profile carefully with their provider.

Hematocrit Testosterone can increase red blood cell production. While this effect is more pronounced in men, it should be monitored in women on therapy as well, particularly those on higher doses.

Liver Health Topical and injectable preparations have a favorable liver safety profile compared to oral androgens, which are not commonly used in women’s hormone therapy today.

Pregnancy and Contraception Testosterone therapy is contraindicated in pregnancy. Women of reproductive age who may become pregnant should discuss appropriate contraception with their provider before starting therapy.

A Client Story — Finding the Right Balance

One of my patients, I will call her Diane came to us at 48 years old feeling, in her words, “like someone turned the lights off.” She was tired, her libido had essentially disappeared, she was struggling to build muscle despite working out consistently, and she felt emotionally flat in a way she could not explain. Her conventional doctor had told her everything was “fine” based on standard blood work.

When we ran her comprehensive panel, we found her free testosterone was at the low end of the range, her SHBG was elevated due to oral estrogen she had been taking for years, and her thyroid was borderline low. Her total testosterone looked passable on paper, but the combination of high SHBG and suboptimal thyroid function meant very little was actually available for her tissues.

We adjusted her estrogen delivery from oral to transdermal (which lowers SHBG), optimized her thyroid support, and introduced a low-dose topical testosterone. After six weeks, her free testosterone had improved meaningfully. After three months, she described herself as “back.” Her energy was returning, her interest in her relationship had rekindled, and she was making visible progress in the gym.

Diane’s story illustrates why dosage cannot be divorced from context. The right testosterone dose is the one that works for your specific physiology — not a number pulled from a chart.

 

FAQs:

  1. Do women actually need testosterone? Yes. Testosterone is produced naturally in women and supports energy, libido, muscle mass, bone density, cognition, and mood. Declining levels — which typically begin in a woman’s twenties and accelerate around perimenopause — can have meaningful effects on quality of life. When clinical symptoms align with low lab values, testosterone therapy may be an appropriate intervention.
  2. What is the normal testosterone level for women? Most labs cite a reference range of approximately 15 to 70 ng/dL for total testosterone in women, though reference ranges vary. Free testosterone, the biologically active fraction, is often a more clinically useful marker. It is important to note that “normal” on a standard lab range does not always mean “optimal” for an individual woman.
  3. Is testosterone therapy safe for women? When dosed appropriately to keep levels within the physiological premenopausal range, testosterone therapy has a favorable safety profile for women. The most common side effects are related to excess dosing and include acne, increased facial hair, and oily skin. These are generally dose-dependent and resolve with dose reduction.
  4. Will testosterone therapy make me look or sound more masculine? Not when dosed appropriately. Significant virilizing effects — such as voice deepening or marked clitoral enlargement — are associated with supraphysiological dosing far above what is used in women’s hormone therapy. Physiologically dosed testosterone does not cause these effects in most women.
  5. How long does it take to feel the effects of testosterone therapy? Many women begin to notice improvements in energy and libido within four to six weeks. Full benefits, including changes in body composition and mood, often develop over three to six months of consistent therapy and appropriate monitoring.
  6. Can testosterone therapy affect fertility? Yes. Testosterone therapy can suppress ovulation and is contraindicated in women who are pregnant or planning pregnancy. Women of reproductive age who are considering testosterone therapy should discuss contraception and family planning with their provider.
  7. Do I need to take estrogen too if I am on testosterone therapy? Not necessarily. The need for combined therapy depends on your hormone levels, symptoms, menopausal status, and clinical picture. Some women benefit from testosterone alone; others need a more comprehensive hormone protocol that includes estrogen and/or progesterone. This is individualized based on labs and symptoms.
  8. What is the difference between testosterone pellets and cream for women? Pellets are implanted subcutaneously and release testosterone steadily over several months, eliminating the need for daily administration. Creams require daily application but allow for easier dose adjustments. Both can be effective; the right choice depends on lifestyle, preference, and clinical judgment.
  9. Can high testosterone cause problems in women? Yes. Supraphysiological testosterone levels in women can cause acne, hirsutism, scalp hair thinning, and other androgenic effects. This is why staying within the physiologically appropriate range and monitoring regularly is essential.
  10. How do I know if I have low testosterone? Symptoms such as low libido, persistent fatigue, difficulty building muscle, brain fog, and low mood may suggest suboptimal testosterone. However, these symptoms overlap with many other conditions, so comprehensive lab testing combined with clinical evaluation is the appropriate starting point. A provider experienced in hormonal health can help you interpret your results in context.
  11. Is testosterone therapy available via telehealth? Yes, at 1st Optimal, we offer remote consultations that include comprehensive lab review and individualized hormone therapy protocols. A detailed evaluation is always conducted before any therapy is recommended.
  12. How often do testosterone levels need to be monitored? During the initial phase of therapy, we typically recheck labs at four to six weeks and again at three months. Once stable, monitoring every three to six months is generally appropriate. Frequency may increase if dosing adjustments are made or if side effects occur.

 

Conclusion

Testosterone is not a male hormone. It is a human hormone, one that women need at physiologically appropriate levels throughout their lives. When those levels decline, the effects are real and the consequences for quality of life are meaningful.

But dosing testosterone for women requires more than picking a number. It requires comprehensive lab assessment, an understanding of how testosterone interacts with the rest of the hormonal system, careful titration, and ongoing monitoring by a provider who knows what to look for.

At 1st Optimal, we take a precision approach to hormone optimization. We do not guess, and we do not generalize. We use your labs, your symptoms, and your goals to build a protocol that makes sense for you and we adjust it as your needs evolve.

If you have been dismissing symptoms of hormonal decline as “just getting older,” I would encourage you to reconsider. Getting older does not have to mean feeling less capable or less like yourself. With the right support, it can mean something very different.

Schedule your consultation today at https://www.1stoptimal.com/consultation

Explore comprehensive lab testing at https://www.1stoptimal.com/lab-testing

Learn about women’s hormone therapy at https://www.1stoptimal.com/womens-hormone-therapy

 

References:

  1. Davison SL, Davis SR. Androgens in women. J Steroid Biochem Mol Biol. 2003.
  2. Burger HG. Androgen production in women. Fertil Steril. 2002. 
  3. Rosner W, et al. Utility, limitations, and pitfalls in measuring testosterone. J Clin Endocrinol Metab. 2007. 
  4. Davis SR, et al. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019. 
  5. Islam RM, et al. Safety and efficacy of testosterone for women. Lancet Diabetes Endocrinol. 2019. 
  6. Wierman ME, et al. Androgen therapy in women: a reappraisal. J Clin Endocrinol Metab. 2014. 
  7. Shifren JL, et al. Sexual problems and distress in United States women. Obstet Gynecol. 2008. 
  8. Glaser R, Dimitrakakis C. Testosterone therapy in women: myths and misconceptions. Maturitas. 2013. 
  9. Longcope C. Adrenal and gonadal androgen secretion in normal females. J Clin Endocrinol Metab. 1986. 
  10. Traish AM, et al. The dark side of testosterone deficiency. J Androl. 2009. 
  11. Bhasin S, et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry. J Clin Endocrinol Metab. 2011. 
  12. Somboonporn W, Davis SR. Testosterone effects on the breast. Endocr Rev. 2004. 
  13. Braunstein GD, et al. Female sexual dysfunction. Curr Opin Obstet Gynecol. 2007. 
  14. Labrie F, et al. DHEA and intracrinology at menopause, a positive choice for evolution of the menopause hormone therapy. Climacteric. 2011. 
  15. Stanczyk FZ. Pharmacokinetics and potency of progestins used for hormone replacement therapy. Am J Obstet Gynecol. 2003. 
  16. Archer JS, et al. Hormone component effects on mood and quality of life. J Reprod Med. 1999. 
  17. Dimitrakakis C, Glaser R. Testosterone and breast cancer. Expert Rev Anticancer Ther. 2015. 
  18. Panjari M, Davis SR. Topical DHEA therapy for women. Menopause. 2011.
  19. Munarriz R, et al. Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction. J Sex Med. 2006. 
  20. Cappola AR. Testosterone therapy in women. JAMA. 2019. 
  21. Nijland EA, et al. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women. J Sex Med. 2008. 
  22. Somboonporn W, et al. Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev. 2005. 
  23. Davis SR, Wahlin-Jacobsen S. Testosterone in women — the clinical significance. N Engl J Med. 2015. 
  24. Morales AJ, et al. Natural sex steroids and their relation to reproductive hormones. Hum Reprod. 1998.
  25. Labrie F, et al. Role of intracrinology in menopause management. Climacteric. 2007.